{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:24:41Z","timestamp":1790846681914,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003079.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T00:00:00Z","timestamp":1512691200000}}],"reference-count":144,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003079.pub4","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T15:23:04Z","timestamp":1379517784000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Benzodiazepines for psychosis-induced aggression or agitation"],"prefix":"10.1002","volume":"2023","author":[{"given":"Hadar","family":"Zaman","sequence":"additional","affiliation":[{"name":"Bradford School of Pharmacy & Medical Sciences, Faculty of Life Sciences; University of Bradford; Bradford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J","family":"Sampson","sequence":"additional","affiliation":[{"name":"Centre for Reviews and Dissemination; University of York; York UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison LS","family":"Beck","sequence":"additional","affiliation":[{"name":"Trust HQ; South London and Maudsley NHS Foundation Trust; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarang","family":"Sharma","sequence":"additional","affiliation":[{"name":"Nordic Cochrane Centre; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona J","family":"Clay","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine; Monash University; Southbank Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Styliani","family":"Spyridi","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Sciences, Faculty of Health Sciences; Cyprus University of Technology; Lemesos Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Zhao","sequence":"additional","affiliation":[{"name":"Systematic Review Solutions Ltd; The Ingenuity Centre, The University of Nottingham; Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Gillies","sequence":"additional","affiliation":[{"name":"Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"10.1002\/14651858.CD003079.pub4-BIB0001|cit1","first-page":"506","article-title":"Alprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia","volume":"149","author":"Barbee","year":"1992","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0002|cit2","first-page":"S114","article-title":"A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms","volume":"38","author":"Chouinard","year":"1993","journal-title":"Canadian Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003079.pub4-BIB0003|cit3","first-page":"134","article-title":"Comparison of the effects of clonazepam and haloperidol in the treatment of psychotic breakdown behavior","volume":"7","author":"Qu","year":"1999","journal-title":"Health Psychology Journal"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0004|cit4","unstructured":"Li C Zhu S Wang H Chen H Yu Y Liu D Safety and efficacy of clonazepam, haloperidol and haloperidol combined with clonazepam in the Shanghai Archives of Psychiatry [\u4e0a\u6d77\u7cbe\u795e\u533b\u5b66] [\u4e0a\u6d77\u7cbe\u795e\u91ab\u5b78] 2007 19 3 150 2"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1176\/ajp.136.8.1061","article-title":"Acute high-dose parenteral haloperidol treatment of psychosis","volume":"136","author":"Lerner","year":"1979","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1176\/ajp.156.1.142","article-title":"Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior","volume":"156","author":"Dorevitch","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1176\/ajp.146.12.1598","article-title":"Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation","volume":"146","author":"Garza-Trevino","year":"1989","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003079.pub4-BIB0008|cit8","first-page":"177","article-title":"Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior","volume":"52","author":"Salzman","year":"1991","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0009|cit9","first-page":"139","article-title":"Benzodiazepine augmentation of the treatment of disruptive psychotic behaviour [Review]","volume":"35","author":"Solomon","year":"1990","journal-title":"Progress in Drug Research"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0735-6757(97)90119-4","article-title":"Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study","volume":"15","author":"Battaglia","year":"1997","journal-title":"American Journal of Emergency Medicine"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00004850-199705000-00009","article-title":"Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting","volume":"12","author":"Foster","year":"1997","journal-title":"International Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD003079.pub4-BIB0012|cit12","first-page":"307","article-title":"A prospective randomised double-blind controlled study of the efficacy of lorazepam versus clothiapine in the control of acutely behaviourally disturbed patients","volume":"88","author":"Subramaney","year":"1998","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/j.1875-9114.1998.tb03827.x","article-title":"A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation","volume":"18","author":"Bieniek","year":"1998","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1002\/14651858.CD003079.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0735-6757(02)42249-8","article-title":"Calming versus sedative effects of intramuscular olanzapine in agitated patients","volume":"21","author":"Battaglia","year":"2003","journal-title":"American Journal of Emergency Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003079.pub4-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/archpsyc.59.5.441","article-title":"A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia","volume":"59","author":"Breier","year":"2002","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0016|cit16","doi-asserted-by":"crossref","unstructured":"David SR Battaglia J Alaka K Meehan K Wright P Calming versus sedative effects of IM olanzapine in agitated patients 11th Association of European Psychiatrists Congress; 2002 May 4-8; Stockholm, Sweden","DOI":"10.1016\/S0924-9338(02)80471-0"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0017|cit17","unstructured":"David SR Jones B Alaka K Meehan K Wright P Taylor CC The efficacy of intramuscular olanzapine in acutely agitated patients 155th Annual Meeting of the American Psychiatric Association; 2002 May 18-23; Philadelphia (PA)"},{"issue":"4","key":"10.1002\/14651858.CD003079.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00004714-200108000-00006","article-title":"A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania","volume":"21","author":"Meehan","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3 Suppl. 1","key":"10.1002\/14651858.CD003079.pub4-BIB0019|cit19","first-page":"236","article-title":"TREC-India. A second arm of TREC","volume":"53","author":"Alexander","year":"2002","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.185.1.63","article-title":"Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting: a pragmatic randomised trial of intramuscular lorazepam versus haloperidol plus promethazine","volume":"185","author":"Alexander","year":"2004","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0021|cit21","unstructured":"Alexander J Vellore (India) Christian Medical College 2003"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003079.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1016\/S0924-977X(02)80465-5","article-title":"Oral risperidone in the management of agitated behavior in emergency settings","volume":"12","author":"Veser","year":"2002","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003079.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00131746-200603000-00005","article-title":"Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial","volume":"12","author":"\u00a0Veser","year":"2006","journal-title":"Journal of Psychiatric Practice"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0024|cit24","doi-asserted-by":"crossref","unstructured":"Kong BG Shim JC Lee SK Comparison of the effects of intramuscular antipsychotics injection in the treatment of acute agitation in psychosis European Neuropsychopharmacology 2009 19 S525 6","DOI":"10.1016\/S0924-977X(09)70833-8"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0025|cit25","unstructured":"Srinath G Shailaja B Sai PG Reddy KA A comparative study of injection haloperidol and promethazine vs. injection lorazepam in controlling acute psychotic agitation Indian Journal of Psychiatry 2010 52 S21"},{"issue":"3 (Suppl 1)","key":"10.1002\/14651858.CD003079.pub4-BIB0026|cit26","first-page":"187","article-title":"TREC III. The protocol and progress of TREC","volume":"53","author":"Huf","year":"2002","journal-title":"Schizophrenia Research"},{"issue":"11","key":"10.1002\/14651858.CD003079.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-244X-2-4","article-title":"TREC-Rio trial: a randomised controlled trial for rapid tranquillisation for agitated patients in emergency psychiatric rooms","volume":"2","author":"Huf","year":"2002","journal-title":"BMC Psychiatry"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0028|cit28","unstructured":"Huf G Coutinho ESF Adams CE The pharmacological management of agitated patients in emergency psychiatric hospitals in Rio de Janeiro, Brazil: the results of two pragmatic randomized clinical trials 5th European Congress on Violence in Clinical Psychiatry; 2007 Oct 25-27; Amsterdam, The Netherlands \u00a0"},{"issue":"3","key":"10.1002\/14651858.CD003079.pub4-BIB0029|cit29","first-page":"236","article-title":"TREC II. Current practices in managing acutely disturbed patients at three hospitals in Rio de Janeiro, Brazil","volume":"53","author":"Huf","year":"2002","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0030|cit30","unstructured":"Huf G Haloperidol plus promethazine versus haloperidol for psychosis induced aggression Data on file 2004 18433659"},{"issue":"7417","key":"10.1002\/14651858.CD003079.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/bmj.327.7417.708","article-title":"Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine","volume":"327","author":"TREC Collaborative Group","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD003079.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annemergmed.2005.07.003","article-title":"Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department","volume":"47","author":"Knott","year":"2006","journal-title":"Annals of Emergency Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003079.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1590\/S1516-44462011000100008","article-title":"Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone","volume":"33","author":"Baldacara","year":"2011","journal-title":"Revista Brasileire da Psiquiatria"},{"issue":"1","key":"10.1002\/14651858.CD003079.pub4-BIB0034|cit34","first-page":"77","article-title":"The use of benzodiazepines for psychotic disorders: a literature review and preliminary clinical findings","volume":"22","author":"Arana","year":"1986","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0035|cit35","unstructured":"\u9f50\u62c9\u897f\u916e\u5408\u5e76\u6c2f\u785d\u897f\u6cee\u6cbb\u7597\u6025\u6027\u671f\u4f34\u6fc0\u8d8a\u7cbe\u795e\u5206\u88c2\u75c7\u60a3\u8005\u7684\u5bf9\u7167\u7814\u7a76 \u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7 2012 4 217 9"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0036|cit36","doi-asserted-by":"crossref","unstructured":"Currier GW Simpson GA Risperidone oral solution versus intramuscular haloperidol for control of psychotic agitation European Neuropsychopharmacology 2000 10 Suppl 3 S296","DOI":"10.1016\/S0924-977X(00)80324-7"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0037|cit37","doi-asserted-by":"crossref","unstructured":"Currier GW Chou JC Feifel D Bossie CA Turkoz I Mahmoud R Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam Journal of Clinical Psychiatry 2004 65 3 386 94 15096079","DOI":"10.4088\/JCP.v65n0315"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003079.pub4-BIB0038|cit38","first-page":"163","article-title":"The emergency treatment of acutely agitated psychotic schizophrenia patients","volume":"11","author":"Davis","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0039|cit39","unstructured":"The combination of risperidone clonazepam therapy of acute schizophrenia excited state efficacy Chinese Journal of Practical Internal Medicine 2004 24 8 496 7"},{"issue":"9","key":"10.1002\/14651858.CD003079.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"844","DOI":"10.4103\/1735-1995.170598","article-title":"Comparison of haloperidol and midazolam in restless management of patients referred to the emergency department: a double-blinded, randomized clinical trial","volume":"20","author":"Esmailian","year":"2015","journal-title":"Journal of Research in Medical Sciences"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0041|cit41","unstructured":"Ge Q Liang X Wang X A comparative study of risperidone combining clonazepam and haloperidol in the treatment of patients with schizophrenia Shandong Archives of Psychiatry [\u5c71\u4e1c\u7cbe\u795e\u533b\u5b66] 2004 17 3 134 6"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0042|cit42","unstructured":"Gharabawi G Turkoz I Pandina G Emergency treatment of acute agitation in patients with schizophrenia and schizoaffective disorder: oral risperidone + lorazepam versus IM haloperidol + lorazepam International Congress on Schizophrenia Research Biennial Meeting; 2003 Mar 29-Apr 2; Colorado Springs (CO)"},{"issue":"12","key":"10.1002\/14651858.CD003079.pub4-BIB0043|cit43","first-page":"767","article-title":"The therapeutic effects of lorazepam in psychotic patients treated with haloperidol: a double blind study","volume":"14","author":"Guz","year":"1972","journal-title":"Therapeutic Research Press"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0044|cit44","unstructured":"Guz I Lorazepam and haloperidol in the treatment of schizophrenic patients Jornal Brasileira de Psiquiatria 1988 37 4 205 7"},{"issue":"9","key":"10.1002\/14651858.CD003079.pub4-BIB0045|cit45","first-page":"631","article-title":"Efficacy of risperidone, clonazepam in the treatment of excitement state of schizophrenia","volume":"27","author":"Han","year":"2005","journal-title":"Ningxia Medical Journal"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/009127006200200305","article-title":"A reference study of ataraxics: a two-week double blind outpatient evaluation","volume":"2","author":"Hankoff","year":"1962","journal-title":"Journal of New Drugs"},{"issue":"3","key":"10.1002\/14651858.CD003079.pub4-BIB0047|cit47","first-page":"171","article-title":"Comparative effects of fluphenazine, fluphenazine-chlordiazepoxide and fluphenazine-imipramine","volume":"31","author":"Hanlon","year":"1970","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0048|cit48","unstructured":"The clonazepam intramuscular combination of aripiprazole treatment of men with acute schizophrenia excited control study Medical Journal of Chinese Civil Administration [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66] 2011 23 13 1588 9 Biosis:prev201100319442"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0049|cit49","unstructured":"Risperidone oral solution with lorazepam treatment of schizophrenia excited state China Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7] 2011 19 7 787 9 Biosis:prev201100319442"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0050|cit50","doi-asserted-by":"crossref","unstructured":"Huf G Coutinho ESF Adams CE Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine BMJ 2007 335 7625 869 72 17954515","DOI":"10.1136\/bmj.39339.448819.AE"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0051|cit51","doi-asserted-by":"crossref","unstructured":"Hwang TJ Chen YH Huang LC Huang GH Hwu HG Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam in the treatment of acute agitation in schizophrenia European Neuropsychopharmacology 2012 22 Suppl 2 S333 S4","DOI":"10.1016\/S0924-977X(12)70513-8"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0052|cit52","doi-asserted-by":"crossref","unstructured":"Isbister GK Calver LA Page CB Stokes B Bryant JL Downes MA Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: the DORM study Annals of Emergency Medicine 2010 56 4 392 401","DOI":"10.1016\/j.annemergmed.2010.05.037"},{"issue":"4","key":"10.1002\/14651858.CD003079.pub4-BIB0053|cit53","first-page":"221","article-title":"Clinical study on efficacy of quetiapine combined with clonazepam treated with acute agitation in schizophrenia patients","volume":"16","author":"Kang","year":"2006","journal-title":"Linchuang Jingshen Yixue Zazhi"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0054|cit54","doi-asserted-by":"crossref","unstructured":"Kinon B Rotelli MD Gilmore JA Efficacy of olanzapine and adjunctive lorazepam to control agitation in schizophrenia International Journal of Neuropsychopharmacology 2002 5 Suppl 1 S128","DOI":"10.1016\/S0924-977X(01)80353-9"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0055|cit55","doi-asserted-by":"crossref","unstructured":"Kinon BJ Ahl J Rotelli MD McMullen E Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia American Journal of Emergency Medicine 2004 22 3 181 6 15138953","DOI":"10.1016\/j.ajem.2004.02.021"},{"issue":"2","key":"10.1002\/14651858.CD003079.pub4-BIB0056|cit56","first-page":"47","article-title":"Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study","volume":"53","author":"Lenox","year":"1992","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0057|cit57","unstructured":"Clonazepam and haloperidol on patients with acute agitation control study Medical Journal of Chinese Civil Administration 2003 15 5 293 4"},{"issue":"12","key":"10.1002\/14651858.CD003079.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1197\/j.aem.2005.07.017","article-title":"Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam","volume":"12","author":"Martel","year":"2005","journal-title":"Academic Emergency Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003079.pub4-BIB0059|cit59","first-page":"1176","article-title":"Clinical observation on acute excitation of schizophrenia treated with QIWEI combined with clonazepam","volume":"20","author":"Mei","year":"2006","journal-title":"Chinese Nursing Research"},{"issue":"8","key":"10.1002\/14651858.CD003079.pub4-BIB0060|cit60","first-page":"687","article-title":"Treatment of 80 cases of schizophrenia manifesting acute erethitic symptoms with quetiapine combined with clonazepam","volume":"24","author":"Wang","year":"2005","journal-title":"Herald of Medicine"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0061|cit61","unstructured":"IM olanzapine versus IM haloperidol plus lorazepam for acute agitation in schizophrenia clinicaltrials.gov\/ct2\/show\/study\/NCT00797277"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0062|cit62","unstructured":"Efficacy and safety of risperidone oral solution combination clonazepam versus haloperidol intramuscular (IM) injection for treatment of acute psychotic agitation in schizophrenia clinicaltrials.gov\/ct2\/show\/NCT00859872"},{"issue":"4-6","key":"10.1002\/14651858.CD003079.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0278-5846(82)80141-3","article-title":"Diazepam in high doses is effective in schizophrenia","volume":"6","author":"Nestoros","year":"1982","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD003079.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1553-2712.2004.tb00738.x","article-title":"A prospective, double-blind, randomized trial of midazolam versus haloperidol versus lorazepam in the chemical restraint of violent and severely agitated patients","volume":"11","author":"Nobay","year":"2004","journal-title":"Academic Emergency Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003079.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0736-4679(98)00045-6","article-title":"Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol","volume":"16","author":"Richards","year":"1998","journal-title":"Journal of Emergency Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003079.pub4-BIB0066|cit66","first-page":"135","article-title":"Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation","volume":"62","author":"Currier","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0067|cit67","unstructured":"Simpson GM Morein JD Reyes-Harde M Gharabawi G A pragmatic and convenient approach for the management or acute agitation: results from a series of clinical studies 16th European College of Neuropsychopharmacology Congress; 2003 Sept 20-24; Prague, Czech Republic"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0068|cit68","doi-asserted-by":"crossref","unstructured":"Stevens A Stevens I Mahal A Gaertner HJ Haloperidol and lorazepam combined: clinical effects and drug plasma levels in the treatment of acute schizophrenic psychosis Pharmacopsychiatry 1992 25 6 273 7 1494594","DOI":"10.1055\/s-2007-1014421"},{"issue":"3","key":"10.1002\/14651858.CD003079.pub4-BIB0069|cit69","first-page":"153","article-title":"A clinical study of risperidone oral solution combined with clonazepam injection in the treatment of acute excitement phase schizophrenia patient","volume":"19","author":"Tang","year":"2007","journal-title":"Shanghai Archives of Psychiatry"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1016\/j.eurpsy.2016.01.2287","article-title":"Pharmacotherapy of acute psychotic states: the reason for benzodiazepines and valproic acid augmentation","volume":"33","author":"Veraksa","year":"2016","journal-title":"European Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003079.pub4-BIB0071|cit71","first-page":"23","article-title":"Curative effect of risperidone with BDZs in the treatment of excitement and agitation with schizophrenia in acute phase","volume":"13","author":"Wan","year":"2005","journal-title":"Chinese Journal of Health Psychology"},{"issue":"2","key":"10.1002\/14651858.CD003079.pub4-BIB0072|cit72","first-page":"88","article-title":"A multicenter study of risperidone treatment for acute agitation in patients with schizophrenia","volume":"37","author":"Wang","year":"2004","journal-title":"Chinese Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0073|cit73","unstructured":"Wetzel H Klawe CJ Muller MJ Wiesner J Benkert O Lorazepam for stupor and mutism: a double-blind placebo-controlled cross-over study 10th European College of Neuropsychopharmacology Congress; 1997 Sept 13-17; Vienna, Austria 1494594"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0074|cit74","unstructured":"Wu Z Risperidone combined clonazepam treatment of acute schizophrenia psychomotor excitement Journal of Qiqihar Medical College [Qiqihar Yixueyuan xuebao][\u9f4a\u9f4a\u54c8\u723e\u91ab\u5b78\u9662\u5b78\u5831] 2006 27 5 536 7"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0075|cit75","unstructured":"Wu Z The combination of risperidone clonazepam in the treatment of acute schizophrenia research psychomotor excitement Journal of Qiqihar Medical College [Qiqihar Yixueyuan xuebao][\u9f4a\u9f4a\u54c8\u723e\u91ab\u5b78\u9662\u5b78\u5831] 2006 27 8 913 4"},{"issue":"1","key":"10.1002\/14651858.CD003079.pub4-BIB0076|cit76","first-page":"126","article-title":"The use of midazolam in acutely agitated psychiatric patients","volume":"26","author":"Wyant","year":"1990","journal-title":"Psychopharmacology Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD003079.pub4-BIB0077|cit77","first-page":"98","article-title":"A randomly controlled comparison of risperidone added with intramuscular clonazepam in the treatment of excitement of schizophrenia","volume":"15","author":"Yang","year":"2003","journal-title":"Shanghai Archives of Psychiatry"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0078|cit78","unstructured":"Yang S Quetiapine combination clonazepam diazepam treatment of acute schizophrenia clinical studies of excitement Journal of Qiqihar Medical College [Qiqihar Yixueyuan xuebao][\u9f4a\u9f4a\u54c8\u723e\u91ab\u5b78\u9662\u5b78\u5831] 2006 27 9 1034 5"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0079|cit79","unstructured":"Yu J Risperidone combined clonazepam controlled study of the treatment of acute schizophrenia Nervous Diseases and Mental Hygiene 2006 6 2 129 30"},{"issue":"4","key":"10.1002\/14651858.CD003079.pub4-BIB0080|cit80","first-page":"239","article-title":"Study of olanzapine combined with clonazepam in treatment of schizophrenia with acute psychomotor excitation","volume":"17","author":"Zhang","year":"2007","journal-title":"Linchuang Jingshen Yixue Zazhi"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0081|cit81","unstructured":"Zhang Y Efficacy of quetiapine combined clonazepam treatment of acute schizophrenia excited Shandong Archives of Psychiatry [\u5c71\u4e1c\u7cbe\u795e\u533b\u5b66] 2008 21 1 59 60"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0082|cit82","unstructured":"Zhong Y Risperidone combining clonazepam and haloperidol in the treatment of first episode of acute schizophrenia clinical control study \u4e2d\u56fd\u533b\u836f\u5bfc\u62a5 2006 3 32 69 70"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0083|cit83","doi-asserted-by":"crossref","unstructured":"\u5229\u57f9\u916e\u53e3\u670d\u6db2\u5408\u5e76\u6c2f\u785d\u897f\u6cee\u6cbb\u7597\u7cbe\u795e\u5206\u88c2\u75c7\u5174\u594b\u6fc0\u8d8a\u75c7\u72b6\u7684\u968f\u673a\u5bf9\u7167\u7814\u7a76 \u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7 2012 8 1123 4","DOI":"10.37155\/2661-4766-0403-21"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0084|cit84","unstructured":"\u9f50\u62c9\u897f\u916e\u8054\u5408\u6c2f\u785d\u897f\u6cee\u6cbb\u7597\u7cbe\u795e\u5206\u88c2\u75c7\u6025\u6027\u671f\u5174\u594b\u6fc0\u8d8a\u75c7\u72b6\u5bf9\u7167\u7814\u7a76 \u957f\u6cbb\u533b\u5b66\u9662\u5b66\u62a5 2014 20 2 17 20"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0085|cit85","unstructured":"Zhu C Fu R Yang Y Sodium valproate and clonazepam for the treatment of agitated symptoms of patients with schizophrenia: a controlled trial Medical Journal of the Chinese People's Armed Police Forces 2005 16 12 934 5 18433659"},{"issue":"4","key":"10.1002\/14651858.CD003079.pub4-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007445.pub2","article-title":"Chlorpromazine for psychosis induced aggression or agitation","author":"Ahmed","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD003079.pub4-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009412","article-title":"Risperidone for psychosis induced aggression or agitation","author":"Ahmed","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl 14","key":"10.1002\/14651858.CD003079.pub4-BIB0088|cit88","first-page":"11","article-title":"Managing the agitated psychotic patient: a reappraisal of the evidence","volume":"61","author":"Allen","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003079.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00131746-200511001-00002","article-title":"The expert consensus guideline series. Treatment of behavioural emergencies","volume":"11","author":"Allen","year":"2005","journal-title":"Journal of Psychiatric Practice"},{"issue":"9","key":"10.1002\/14651858.CD003079.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2165\/00003495-200565090-00003","article-title":"Pharmacological management of acute agitation","volume":"65","author":"Battaglia","year":"2005","journal-title":"Drugs"},{"issue":"2","key":"10.1002\/14651858.CD003079.pub4-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003729.pub2","article-title":"Olanzapine IM or velotab for acutely disturbed\/agitated people with suspected serious mental illnesses","author":"Belgamwar","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD003079.pub4-BIB0093|cit93","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"issue":"7","key":"10.1002\/14651858.CD003079.pub4-BIB0094|cit94","first-page":"28","article-title":"The Clinical Global Impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003079.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0022-3956(82)90031-0","article-title":"The stability of the symptom groupings in the Inpatient Multidimensional Psychiatric Scale (IMPS)","volume":"17","author":"Cairns","year":"1983","journal-title":"Journal of Psychiatric Research"},{"issue":"1","key":"10.1002\/14651858.CD003079.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00001199-199902000-00012","article-title":"Reliability of the Agitated Behaviour Scale","volume":"14","author":"Caplan","year":"1999","journal-title":"Journal of Head Trauma Rehabilitation"},{"issue":"4","key":"10.1002\/14651858.CD003079.pub4-BIB0097|cit97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001943.pub2","article-title":"Loxapine for schizophrenia","author":"Chakrabarti","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0098|cit98","first-page":"487","article-title":"Agitation following traumatic head injury","volume":"69","author":"Corrigan","year":"1988","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0099|cit99","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data 8th International Cochrane Colloquium; 2000 Oct 25-28; Cape Town, South Africa 2000"},{"issue":"6","key":"10.1002\/14651858.CD003079.pub4-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003079.pub4-BIB0101|cit101","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001359","article-title":"Olanzapine for schizophrenia","author":"Duggan","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7109","key":"10.1002\/14651858.CD003079.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD003079.pub4-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD003079.pub4-BIB0104|cit104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000059","article-title":"Clozapine versus typical neuroleptic medication for schizophrenia","author":"Essali","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-1781(89)90041-3","article-title":"Correlations between the MMPI and the Brief Psychiatric Rating Scale in schizophrenic and schizoaffective patients","volume":"28","author":"Faustman","year":"1989","journal-title":"Psychiatry Research"},{"issue":"7","key":"10.1002\/14651858.CD003079.pub4-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD003079.pub4-BIB0107|cit107","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000525.pub3","article-title":"Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses","author":"Jayakody","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD003079.pub4-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v67n0702","article-title":"Pharmacotherapy for the treatment of aggressive behavior in general adult psychiatry: a systematic review","volume":"67","author":"Goedhard","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD003079.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0110|cit110","first-page":"12","volume-title":"Manual for the ECDEU Assessment Battery","author":"Guy","year":"1970"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0111|cit111","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]","author":"Higgins","year":"2008"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0112|cit112","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-244X-2-4","article-title":"Current practices in managing acutely disturbed patients at three hospitals in Rio de Janeiro-Brazil: a prevalence study","volume":"2","author":"Huf","year":"2002","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003079.pub4-BIB0114|cit114","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005146.pub2","article-title":"Haloperidol plus promethazine for psychosis-induced aggression","author":"Huf","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003079.pub4-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1258\/td.2010.100300","article-title":"Rapid tranquillization agents for severe behavioural disturbance: a survey of African psychiatrists' prescription patterns","volume":"41","author":"James","year":"2011","journal-title":"Tropical Doctor"},{"issue":"2","key":"10.1002\/14651858.CD003079.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive And Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophrenia Bulletin"},{"issue":"5","key":"10.1002\/14651858.CD003079.pub4-BIB0117|cit117","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009830","article-title":"Haloperidol for long-term aggression in psychosis","author":"Khushu","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD003079.pub4-BIB0118|cit118","first-page":"55","article-title":"Comparing drugs for short-term sedation","volume":"6","author":"Larson","year":"1994","journal-title":"Contemporary Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003079.pub4-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/schbul\/sbl025","article-title":"Is the superior efficacy of new generation antipsychotics an artifact of LOCF?","volume":"33","author":"Leucht","year":"2007","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0120|cit120","volume-title":"Inpatient Multidimensional Psychiatric Scale","author":"Lorr","year":"1963"},{"issue":"Suppl 10","key":"10.1002\/14651858.CD003079.pub4-BIB0121|cit121","first-page":"13","article-title":"A review of agitation in mental illness: treatment guidelines and current therapies","volume":"67","author":"Marder","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"issue":"Suppl 10","key":"10.1002\/14651858.CD003079.pub4-BIB0123|cit123","first-page":"3","article-title":"Rapid tranquillization agents for severe behavioural disturbance: a survey of African psychiatrists' prescription patterns","volume":"67","author":"Mintzer","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"15","key":"10.1002\/14651858.CD003079.pub4-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD003079.pub4-BIB0125|cit125","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002084.pub2","article-title":"Containment strategies for people with serious mental illness","author":"Muralidharan","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0126|cit126","unstructured":"National Institute for Health and Care Excellence Violence: the short-term management of disturbed\/violent behaviour in psychiatric in-patient settings and emergency departments, NG10 www.nice.org.uk\/guidance\/ng10"},{"issue":"2","key":"10.1002\/14651858.CD003079.pub4-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archpsyc.1967.01730200014003","article-title":"Major psychiatric disorders: a four dimensional model","volume":"16","author":"Overall","year":"1967","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003079.pub4-BIB0128|cit128","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008074","article-title":"Aripiprazole for psychosis-induced aggression or agitation","author":"Pagadala","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD003079.pub4-BIB0129|cit129","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009377","article-title":"Haloperidol (rapid tranquilisation) for psychosis induced aggression or agitation","author":"Powney","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/bmj.2.5920.656","article-title":"Controlled sedation with alphaxalone-alphadolone","volume":"2","author":"Ramsay","year":"1974","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD003079.pub4-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.pnpbp.2006.01.015","article-title":"Managing the aggressive and violent patient in the psychiatric emergency","volume":"30","author":"Rocca","year":"2006","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003079.pub4-BIB0132|cit132","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001163","article-title":"Seclusion and restraint for people with serious mental illnesses","author":"Sailas","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/9780470712184.ch12","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD003079.pub4-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1037\/1040-3590.17.3.324","article-title":"Meta-analysis of the Brief Psychiatric Rating Scale factor structure","volume":"17","author":"Shafer","year":"2005","journal-title":"Psychological Assessment"},{"issue":"2","key":"10.1002\/14651858.CD003079.pub4-BIB0135|cit135","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001357","article-title":"Amisulpride for schizophrenia","author":"Silveira da Mota Neto","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003079.pub4-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.185.1.63","article-title":"Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting: a pragmatic randomised trial of intramuscular lorazepam versus haloperidol plus promethazine","volume":"185","author":"Alexander","year":"2004","journal-title":"British Journal of Psychiatry"},{"issue":"7417","key":"10.1002\/14651858.CD003079.pub4-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/bmj.327.7417.708","article-title":"Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine","volume":"327","author":"TREC Collaborative Group","year":"2003","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD003079.pub4-BIB0138|cit138","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010190","article-title":"Loxapine inhaler for psychosis-induced aggression or agitation","author":"Vangala","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003079.pub4-BIB0139|cit139","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006391","article-title":"Benzodiazepines for schizophrenia","author":"Volz","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003079.pub4-BIB0140|cit140","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009801","article-title":"Quetiapine for psychosis-induced aggression or agitation","author":"Wilkie","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD003079.pub4-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD003079.pub4-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1176\/ajp.143.1.35","article-title":"The Overt Aggression Scale for the objective rating of verbal and physical aggression","volume":"143","author":"Yudofsky","year":"1986","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003079.pub4-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1176\/jnp.9.4.541","article-title":"The Overt Agitation Severity Scale for the objective rating of agitation","volume":"9","author":"Yudofsky","year":"1997","journal-title":"Journal of Neuropsychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003079.pub4-BIB0144|cit144","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003079.pub2","article-title":"Benzodiazepines for psychosis-induced aggression or agitation","author":"Gillies","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T02:19:24Z","timestamp":1689905964000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003079.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":144,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003079.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,8]]}}}